Has Rebecca Ward received payments from drug or device companies?

Yes. Drug and device makers reported $1,578 in general payments to Rebecca Ward across 15 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rebecca Ward did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rebecca Ward come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rebecca Ward

Nurse Practitioner · West Reading, PANPI 1396060166

Payments from drug & device makers

$1,578in general payments, 2019–2025

Across 15 payments — averaging $105.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Paratek Pharmaceuticals, Inc.$429
AbbVie$375
Madrigal Pharmaceuticals$150
Shionogi Inc$125
Lilly USA, LLC$125
AstraZeneca$124
plus $250 from 4 others

What the payments were for

Food & beverage$1,578100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Paratek Pharmaceuticals, Inc.	4	$429
AbbVie	3	$375
Madrigal Pharmaceuticals	1	$150
Shionogi Inc	1	$125
Lilly USA, LLC	1	$125
AstraZeneca	1	$124
Novo Nordisk	1	$100
Inari Medical, Inc.	1	$96
E.r. Squibb & Sons, L.L.C.	1	$40
Merck	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NUZYRA$355
DALVANCE$250
REZDIFFRA$150
Fetroja$125
AVYCAZ$125
ZEPBOUND$125
Saxenda$100

How this compares

$1,578 in reported general payments places this provider in the 85th percentile of 4,059 nurse practitioner providers in Pennsylvania.

See all nurse practitioner providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$60,963

Medicare patients

361

Services billed

727

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Daptomycin	22	$28,258
Cefpodoxime Proxetil	54	$13,305
Doxycycline Monohydrate	109	$7,313
Vancomycin Hcl	42	$6,862
Cefadroxil	119	$5,745
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	68	$3,344
Cefepime Hcl	15	$2,894
Piperacillin-TazobactamPiperacillin Sodium/Tazobactam	13	$1,979
Voriconazole	12	$763
Amoxicillin	37	$568
Cephalexin	40	$525
Clindamycin Hcl	11	$477
Levofloxacin	20	$421
Fluconazole	27	$368
CeftriaxoneCeftriaxone Sodium	18	$345

Paid to pharmacies, not to this prescriber.